Andrew Griffin

This inventor holds 22 USPTO granted patents and 9 published patent applications, plus 2 CIPO patents and 6 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Astrazeneca Ab, Neomed Institute, Epigenetix, Inc.. Active years: 2004-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew Griffin. Retrieved from https://idiyas.com/inventor/andrew-griffin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 22 (Patent Applications = 9)

% Patents Active = 50.0

CIPO Patents = 2 (Patent Applications = 10)

EPO Patents = 6 (Patent Applications = 5)

Average Co-Inventor Count = 3.5

ph-index = 3

Forward Citations = 22(Granted Patents)

Location History:

St. Laurent, CA (2004 - 2011)
Québec, CA (2011 - 2015)
Montreal, CA (2006 - 2024)

Company Filing History:

Years Active: 2004-2024

Loading Chart...

Areas of Expertise:

Benzimidazoles

Bicyclic Lactams

Piperazine Derivatives

Dihydroquinolinones

Triazolopyridines

Bromodomain Inhibitors

Cyclopropyl Amides

Aryl Compounds

Pain Treatment

Anxiety Disorders

Gastrointestinal Disorders

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11981657 - Substituted benzimidazoles, their preparation and their use as pharmaceuticals (2024-05-14),

2. 11365186 - Substituted benzimidazoles, their preparation and their use as pharmaceuticals (2022-06-21),

3. 10836742 - N-substituted bicyclic lactams, their preparation and their use as pharmaceuticals (2020-11-17),

4. 10703740 - Substituted benzimidazoles, their preparation and their use as pharmaceuticals (2020-07-07),

5. 10519151 - Substituted [1,2,4]triazolo[4,3-A]pyridines, their preparation and their use as pharmaceuticals (2019-12-31),

6. 10501459 - Substituted imidazo[1,2-a]pyridines as bromodomain inhibitors (2019-12-10),

7. 10501438 - Aryl-substituted dihydroquinolinones, their preparation and their use as pharmaceuticals (2019-12-10),

8. 9029381 - Cyclopropyl amide derivatives (2015-05-12),

9. 8993577 - Cyclopropyl amide derivatives (2015-03-31),

10. 8168668 - Compounds (2012-05-01),

11. 8129393 - Diarylmethyl piperazine derivatives, preparations thereof and uses thereof (2012-03-06),

12. 8063215 - Cyclopropyl amide derivatives (2011-11-22),

13. 7960389 - 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders (2011-06-14),

14. 7618993 - Compounds (2009-11-17),

15. 7396834 - 4(Phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders (2008-07-08),

Title: Andrew Griffin: Pioneering Inventor from Montreal

Introduction: Andrew Griffin is a distinguished inventor based in Montreal, Canada, known for his groundbreaking contributions to various technological fields.

Latest Patents: Andrew Griffin holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his versatility and innovative spirit.

Career Highlights: With over two decades of experience in the industry, Andrew Griffin has led numerous successful projects that have revolutionized the way we approach modern challenges.

Collaborations: Throughout his career, Andrew Griffin has collaborated with leading research institutions, universities, and tech companies, fostering a culture of innovation and knowledge sharing.

Conclusion: Andrew Griffin's passion for innovation and his relentless drive to push the boundaries of technology make him a true trailblazer in the world of inventions.

Profile summary based on public USPTO records.